{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.05"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"description":"Phase 1: to determine MTD of melphalan in combination with panobinostat to be used in the Phase 2 portion of the study","groups":[{"description":"20mg daily LBH589 and 0.05mg/kg melphalan on days 1, 3 and 5 of week 1","id":"OG000","title":"Melphalan and Panobinostat Schedule D3"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"12 months","title":"MTD","type":"PRIMARY","unitOfMeasure":"mg/kg melphalan"}